Exelixis (EXEL) Q1 2024 Earnings Call Transcript
EXEL earnings call for the period ending March 31, 2024.
Stay updated with breaking news from Silvan Tuerkcan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EXEL earnings call for the period ending March 31, 2024.
CNBC Pro screened for global stocks that have received price target upgrades from five or more analysts and have an upside of over 25%.
Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), with a price target ...
EXEL earnings call for the period ending December 31, 2023.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.